Neurosurgical Devices Market By Product Type (Neuroendoscopes, Stereotactic Systems, Ablation Systems {Laser Ablation Systems, Radiofrequency Ablation Systems}, Neurostimulation Devices, Cranial Fixation Devices, Neuroimaging Systems, Neurointerventional Devices {Coils, Stents, Flow Diversion Devices}, Others), By Application (Parkinson’s Disease, Epilepsy, Cerebral Aneurysm, Hydrocephalus, Brain Tumors, Others), By Technology (Open Surgery, Minimally Invasive Surgery, Robotic-Assisted Surgery, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Neurosurgical Devices market accounted for USD 11.25 Billion in 2024 and is expected to reach USD 44.0 Billion by 2035, growing at a CAGR of around 13.2% between 2025 and 2035. The neurosurgical devices market relates to manufacturing and selling equipment used to perform neurosurgery to treat neurological disorders. These gadgets are used by healthcare professionals to diagnose neurological, spinal cord, and brain diseases and also to monitor patients and execute surgeries. It mainly involves neurostimulation devices, neuroimaging systems, neuroendoscopes, stereotactic systems, and cranial fixation systems.

The market is primarily growing due to the rising incidence of neurological disorders like Parkinson's, epilepsy, brain tumors, and spinal problems. As a result, the increase in the utilization of technology, such as the integration of artificial intelligence and robot-assisted surgery, is boosting market growth. The higher prevalence of geriatric populations and the rising need for better and less invasive neurosurgical procedures will continue to create growth in the neurosurgical devices market in the forecast year.

Report Scope:

Market Dynamics

Advancements in Technology Enhancing Surgical Precision and Patient Outcomes

The neurosurgical devices market is driven by advanced technology, rising neurological illnesses, and increased healthcare spending. The use of robots in operating rooms, improved imaging technologies, and minimally invasive surgery have all increased operational precision and overall patient care. According to the World Health Organization, neurological illnesses, such as Alzheimer's disease, stroke, and Parkinson’s disease, is among the most common causes of disability worldwide. The neurosurgical devices market is being driven by rising demand for treatments for various illnesses. Further, advances in material sciences are improving the biocompatibility and longevity of implants needed for complex neurosurgery procedures.

There is a growing global focus on improving healthcare systems and performing better procedures, generating a need for the neurosurgical devices market, particularly in developing countries. The healthcare market is expected to expand, driven by increased spending and advancements in surgical and delivery technology.

Rising Prevalence of Neurological Disorders Fuelling Demand for Neurosurgical Interventions

The increasing incidence of neurological disorders is one of the primary growth factors contributing to the need for neurosurgical devices. Diseases such as brain tumors, strokes, dementia, Parkinson's, and epilepsy are on the rise around the world, owing to an aging population and risk factors. According to the World Health Organization (WHO), neurological disorders affect over one billion people worldwide. Neurological conditions are, unfortunately, among the leading causes of both disability and death. As a result, there is a growing demand for advanced corrective and treatment procedures related to these conditions.

The increase in neurosurgery procedures has demanded advancements in imaging technologies and equipment, neurosurgical devices, and surgical robots to assist patients in surviving and limiting effects. Rising awareness of neurological illnesses, and also improvements in the accessibility and quality of healthcare services around the world, continue to be major market drivers. This shows that healthcare investment has improved to meet these needs.

High-Risk Nature of Neurosurgical Procedures Hindering Adoption of Advanced Devices

A primary limitation in neurosurgical activities is the high-risk nature of performing neurosurgical operations, which restricts the implementation of neurosurgical devices and technology. Neurosurgery is difficult and contains several dangers. Patients may develop neurological disorders, infections, bleeding, and other complications as a result of anesthesia. The National Institute of Neurological Disorders and Stroke (NINDS) has noted that conditions such as brain tumors and strokes can lead to complications that prolong recovery times and create challenges after surgery. Due to these risks, healthcare providers are wary of integrating complicated devices in their courses of patient treatment until evidence proving the worthiness of such tools surfaces.

The adoption of these devices may reduce the likelihood of complications, even though they generally offer better outcomes compared to conventional tools. However, surgeons may hesitate to use new technologies for the same procedures due to the potential risks associated with their adoption. This restraint slows the growth of the neurosurgical devices market, as patient safety is one of the most essential factors in practice.

Significant Growth Potential in Emerging Markets Accelerating Adoption of Neurosurgical Devices

The increased competition in the neurosurgical devices market is attributed to the expanded number of new entrants and abundant market development opportunities in newly industrialized countries. Rapidly developing countries, such as the Indian and Chinese ones in Latin America, are increasing their healthcare expenses, and as a result, require high-quality neurosurgical procedures.

The World Bank has found that emerging markets will spend over 6% annually on healthcare, which will greatly benefit the medical device industry. As modern healthcare systems expand and more complex neurosurgical treatments become available, the use of neurosurgical devices is steadily increasing.

This trend is expected to continue, with the prevalence of neurological disorders rising in some parts of the world. Further, it is believed that as people gain more knowledge about brain diseases, patients will be more likely to seek appropriate treatment, increasing demand for more efficient and sophisticated neurosurgical tools such as robotic systems, minimally invasive technologies, and imaging systems. As a result, manufacturers have a tremendous growth opportunity to expand their market position and meet the demands of these rapidly developing healthcare sectors.

Advancements in Personalized Medicine Paving the Way for Customized Neurosurgical Devices

New developments in biosciences are opening up new opportunities in the NM segment while underscoring the need for site-specific solutions that can address the specific needs of a given patient population. In the case of genetic customization as a branch of personalized medicine, it provides the mechanism for tailoring medical therapy, surgical operations, and neurological conditions in consonance with patients’ genetic characteristics, medical history, and disease states. For instance, manufacturers use 3D printing to create implants and tools for surgeries, while artificial intelligence enhances the design of implants and devices, reducing both surgery and recovery times.

These advancements enable more effective treatment of complex neurological disorders by aligning with the patient's specific morphology and pathology. As claimed by Johns Hopkins Medicine, the effectiveness of personalized medicine in surgeries has been apparent in that it enhances certain bodily recoveries after surgeries and reduces surgical complications. This presents a strong opportunity for neurosurgical device manufacturers to develop equipment tailored to the specific needs of patients, as standard devices often prove ineffective in neurosurgery. This growth can be attributed to technological advancements and changes in living and working conditions that promote individualism, which also influence the neurosurgical devices market.

Industry Experts Opinion

"The SPECTRA was able to illuminate and provide enhanced fluorescence better than ever before to a deep tumor through a very small corridor."

• Analiz Rodriguez, MD, PhD, director of Neurosurgical Oncology.

"Our team is thrilled to achieve this milestone and to have the eShunt System recognized by the FDA as a Breakthrough Device. The ability to collaborate with the FDA under the Breakthrough Program will support our goal to bring an endovascular option to the treatment of patients with NPH.”

• Dan Levangie, Chairman and CEO of CereVasc, Inc.

Segment Analysis

Based on the product type, the neurosurgical devices market has been classified into Neuroendoscopes, Stereotactic Systems, Ablation Systems, Neurostimulation Devices, Cranial Fixation Devices, Neuroimaging Systems, Neurointerventional Devices, and Others. Neurostimulation devices are thus the largest and most developed segment of the neurosurgical devices market. These devices are mostly used in neurological disorders such as Parkinson's disease, epilepsy, and chronic pain, all of which offer alternate therapy options in addition to regular drugs.

The prevalence of neurological illnesses is increasing, and we require new non-invasive treatment options. Deep brain stimulators, spinal stimulators, and transcranial magnetic stimulation equipment are reusable, providing targeted therapy with fewer side effects, and are commonly utilized in neurosurgery procedures.

Based on the application, the neurosurgical devices market has been classified into Parkinson’s Disease, Epilepsy, Cerebral Aneurysm, Hydrocephalus, Brain Tumors, and Others. The brain tumor segment accounts for a bulwark of the neurosurgical devices market. Intracranial tumors, which are found in the brain parenchyma and involve a wide range of space-occupying processes, including both malignant and benign tumors, are common illnesses that frequently require surgical intervention.

Current trends in the incidence of brain tumors, which can be related to demographics, lifestyle, and research environments, among other factors, have raised demand for neurosurgical devices. Neuroimaging systems, neuroendoscopes, and stereotactic systems utilized in brain tumor surgery are important for diagnosis, tumor location assessment, and removal. As a result, this category remains the most crucial for market growth as surgical efficiency improves due to the adoption of technologies that allow for greater efficacy.

Regional Analysis 

The North American neurosurgical devices market is leading due to strong healthcare facilities, high healthcare spending, and an increasing incidence of neurological illnesses. Particularly noteworthy is the United States, which boasts a robust medical device market, leadership in robot-assisted surgery, and a growing market for innovative neuroimaging and neurostimulation equipment. The region enjoys constant improvements in technology, sound policies regarding reimbursement, and key manufacturers of the medical device market. Moreover, the increased life expectancy of the population in North America and the high rate of neurological disorders, including brain tumors and Parkinson’s disease, have created a growing need for sophisticated neurosurgical procedures. These factors mean that North America is by far the biggest and most profitable market for neurosurgical devices.

The Asia-Pacific neurosurgical devices market is the fastest growing due to the regional improvement in healthcare facilities, increased investment in healthcare, and increased consciousness about neurological illness. Chinese, Indian, and Japanese people are already spending more on healthcare owing to increased disposable incomes and improved access to technology.

Increased life expectancy in these countries, combined with an increasing prevalence of neurological illnesses like brain tumors, epilepsy, and Parkinson's disease, will fuel demand for neuraxin surgery. Furthermore, the increasing implementation of reforms and enhanced funding in the healthcare sector by emerging economies drives the growth of the region. Experts anticipate that the Asia Pacific area will experience rapid growth in the coming years as sophisticated technology such as robotic surgical systems and neuroradiology advances.

Competitive Landscape

Neurosurgical Devices Major market players are Medtronic, Stryker Corporation, Johnson & Johnson, Zimmer Biomet, B. Braun Melsungen AG, and Integra LifeSciences. Currently, these companies are working on the concept of innovation, mergers, and acquisitions to solidify the market position. For instance, Medtronic, which forms part of the leading giants in the market, acquired Mazor Robotics to complement robotic support in surgeries related to the spine. Stryker diversifies its product lines by acquiring K2M Group Holdings to improve its disposal of spine surgery products.

Moreover, new neurosurgical products are being developed through research and development for use in neurosurgical procedures, including critical technologies such as AI-based imaging and minimally invasive neurosurgical instruments. These technologies are expected to drive market growth in the coming years. This competitive environment is encouraging the development of more and better technologies and expanding the portfolio of available products to satisfy the needs of neurosurgeons or their patients.

Neurosurgical Devices Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In April 2024, Dr. Reddy’s introduced Nerivio, a drug-free, noninvasive device designed to manage migraines. Supported by Dr. Reddy’s M-free patient support program, Nerivio offers a comprehensive range of services to enhance the patient experience. The program includes patient onboarding, counselling, device demonstrations, doorstep delivery, flexible payment options, informative resources, and dedicated customer care.
• In February 2023, LivaNova PLC, a leading innovator in medical technology, introduced the SenTiva DUO, an implantable pulse generator (IPG) designed to provide VNS Therapy for the treatment of drug-resistant epilepsy. Unlike the original SenTiva, which features a single-pin header, the SenTiva DUO includes a dual-pin header. This enhancement allows patients who were initially implanted with a dual-pin lead and IPG to benefit from the latest advancements in VNS Therapy technology, solidifying their role as "pioneers" of this treatment.

Report Coverage:

By Product Type

• Neuroendoscopes
• Stereotactic Systems
• Ablation Systems
  • Laser Ablation Systems
  •  Radiofrequency Ablation Systems
• Neurostimulation Devices
• Cranial Fixation Devices
• Neuroimaging Systems
• Neurointerventional Devices
  • Coils
  • Stents
  • Flow Diversion Devices
• Others

By Application

• Parkinson’s Disease
• Epilepsy
• Cerebral Aneurysm
• Hydrocephalus
• Brain
• Tumors
• Others

By Technology

• Open Surgery
• Minimally Invasive Surgery
• Robotic-Assisted Surgery
• Others

End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialized Clinics
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Medtronic
• Stryker Corporation
• Zimmer Biomet
• DePuy Synthes
• Brainlab
• Carl Zeiss Medite
• Abbott Laboratories
• Boston Scientific
• NeuroPace
• Integra LifeSciences
• Synaptive Medica
• Terumo Corporation
• KLS Martin
• ACELRX Pharmaceuticals
• Hoya Corporation

Frequently Asked Questions (FAQs)